المؤلفون: Zeru Tian (11984077), Chenfei Yu (1586326), Weijie Zhang (145595), Kuan-Lin Wu (1762933), Chenhang Wang (11984080), Ruchi Gupta (205155), Zhan Xu (6239195), Ling Wu (151826), Yuda Chen (5921747), Xiang H.-F. Zhang (9147414), Han Xiao (373894)

مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Pharmacology, Biotechnology, Ecology, Cancer, Hematology, Plant Biology, Space Science, Mathematical Sciences not elsewhere classified, significantly reduced survival, secondary multiorgan metastases, introduced varying numbers, breast cancer metastasis, enhanced therapeutic efficacy, initial bone metastases, bone metastatic niche, engineering therapeutic antibodies, antibody therapy results, therapeutic antibodies, results demonstrate, engineering strategy, clinical efficacy, unmodified antibody, her2 antibody, antibody therapy, prepare bone, bone tumors, bone tumor

Relation: https://figshare.com/articles/journal_contribution/Bone-Specific_Enhancement_of_Antibody_Therapy_for_Breast_Cancer_Metastasis_to_Bone/18857959

الاتاحة: https://doi.org/10.1021/acscentsci.1c01024.s001

المؤلفون: Cottignies-Calamarte, Andréa, He, Feifan, Zhu, Aiwei, Real, Fernando, Bomsel, Morgane

المساهمون: Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)

المصدر: ISSN: 2666-1667 ; STAR Protocols ; https://hal.science/hal-04253093 ; STAR Protocols, 2023, 4 (4), pp.102593. ⟨10.1016/j.xpro.2023.102593⟩.

مصطلحات موضوعية: antibody-engineering therapeutic antibodies Fc-mediated effector functions chimeric antibody FcgR FcaR/CD89 IgA, antibody-engineering, therapeutic antibodies, Fc-mediated effector functions, chimeric antibody, FcgR, FcaR/CD89, IgA, [SDV]Life Sciences [q-bio]

Relation: hal-04253093; https://hal.science/hal-04253093

الاتاحة: https://hal.science/hal-04253093
https://doi.org/10.1016/j.xpro.2023.102593

المؤلفون: Cottignies-Calamarte, Andréa, He, Feifan, Zhu, Aiwei, Real, Fernando, Bomsel, Morgane

المساهمون: Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)

المصدر: ISSN: 2666-1667 ; STAR Protocols ; https://hal.science/hal-04253093 ; STAR Protocols, 2023, 4 (4), pp.102593. ⟨10.1016/j.xpro.2023.102593⟩.

مصطلحات موضوعية: antibody-engineering therapeutic antibodies Fc-mediated effector functions chimeric antibody FcgR FcaR/CD89 IgA, antibody-engineering, therapeutic antibodies, Fc-mediated effector functions, chimeric antibody, FcgR, FcaR/CD89, IgA, [SDV]Life Sciences [q-bio]

Relation: hal-04253093; https://hal.science/hal-04253093

الاتاحة: https://hal.science/hal-04253093
https://doi.org/10.1016/j.xpro.2023.102593